Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1989 1
1990 1
1992 2
1993 1
1995 9
1996 3
1997 1
1998 4
1999 5
2000 5
2001 8
2002 13
2003 15
2004 10
2005 9
2006 10
2007 6
2008 8
2009 7
2010 11
2011 11
2012 8
2013 5
2014 10
2015 7
2016 4
2017 9
2018 3
2019 8
2020 11
2021 10
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

196 results
Results by year
Filters applied: . Clear all
Page 1
Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. Among authors: fegan c. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. N Engl J Med. 2021. PMID: 32678530 Free PMC article. Clinical Trial.
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.
Hillmen P, Rawstron AC, Brock K, Muñoz-Vicente S, Yates FJ, Bishop R, Boucher R, MacDonald D, Fegan C, McCaig A, Schuh A, Pettitt A, Gribben JG, Patten PEM, Devereux S, Bloor A, Fox CP, Forconi F, Munir T. Hillmen P, et al. Among authors: fegan c. J Clin Oncol. 2019 Oct 20;37(30):2722-2729. doi: 10.1200/JCO.19.00894. Epub 2019 Jul 11. J Clin Oncol. 2019. PMID: 31295041 Free PMC article. Clinical Trial.
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Kennedy E, Coulter E, Halliwell E, Profitos-Peleja N, Walsby E, Clark B, Phillips EH, Burley TA, Mitchell S, Devereux S, Fegan CD, Jones CI, Johnston R, Chevassut T, Schulz R, Seiffert M, Agathanggelou A, Oldreive C, Davies N, Stankovic T, Liloglou T, Pepper C, Pepper AGS. Kennedy E, et al. Among authors: fegan cd. Blood. 2021 Jun 3;137(22):3064-3078. doi: 10.1182/blood.2020005964. Blood. 2021. PMID: 33512408 Free PMC article.
Apoptosis deregulation in CLL.
Fegan C, Pepper C. Fegan C, et al. Adv Exp Med Biol. 2013;792:151-71. doi: 10.1007/978-1-4614-8051-8_7. Adv Exp Med Biol. 2013. PMID: 24014296 Review.
Clinical utility of telomere length measurements in cancer.
Pepper C, Norris K, Fegan C. Pepper C, et al. Among authors: fegan c. Curr Opin Genet Dev. 2020 Feb;60:107-111. doi: 10.1016/j.gde.2020.02.012. Epub 2020 Mar 25. Curr Opin Genet Dev. 2020. PMID: 32220800 Review.
Is venetoclax a new wonder drug in CLL?
Fegan C, Pepper C. Fegan C, et al. Br J Haematol. 2019 May;185(4):643-646. doi: 10.1111/bjh.15836. Epub 2019 Mar 11. Br J Haematol. 2019. PMID: 30859555 No abstract available.
Changing me to we: Developing teambuilding in radiation therapy.
Dawdy K, Fegan C, Sheikh A, Harris S, McGuffin M. Dawdy K, et al. Among authors: fegan c. J Med Imaging Radiat Sci. 2021 Sep;52(3):390-398. doi: 10.1016/j.jmir.2021.04.003. Epub 2021 May 15. J Med Imaging Radiat Sci. 2021. PMID: 34001455
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia.
Lin WY, Fordham SE, Sunter N, Elstob C, Rahman T, Willmore E, Shepherd C, Strathdee G, Mainou-Fowler T, Piddock R, Mearns H, Barrow T, Houlston RS, Marr H, Wallis J, Summerfield G, Marshall S, Pettitt A, Pepper C, Fegan C, Forconi F, Dyer MJS, Jayne S, Sellors A, Schuh A, Robbe P, Oscier D, Bailey J, Rais S, Bentley A, Cawkwell L, Evans P, Hillmen P, Pratt G, Allsup DJ, Allan JM. Lin WY, et al. Among authors: fegan c. Nat Commun. 2021 Jan 28;12(1):665. doi: 10.1038/s41467-020-20822-9. Nat Commun. 2021. PMID: 33510140 Free PMC article.
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.
Zelek WM, Cole J, Ponsford MJ, Harrison RA, Schroeder BE, Webb N, Jolles S, Fegan C, Morgan M, Wise MP, Morgan BP. Zelek WM, et al. Among authors: fegan c. Am J Respir Crit Care Med. 2020 Nov 1;202(9):1304-1308. doi: 10.1164/rccm.202007-2778LE. Am J Respir Crit Care Med. 2020. PMID: 32897730 Free PMC article. No abstract available.
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
Morschhauser F, Dyer MJS, Walter HS, Danilov AV, Ysebaert L, Hodson DJ, Fegan C, Rule SA, Radford J, Cartron G, Bouabdallah K, Davies AJ, Spurgeon S, Rajakumaraswamy N, Li B, Humeniuk R, Huang X, Bhargava P, Jürgensmeier JM, Salles G. Morschhauser F, et al. Among authors: fegan c. Leukemia. 2021 Jul;35(7):2108-2113. doi: 10.1038/s41375-020-01108-x. Epub 2020 Dec 17. Leukemia. 2021. PMID: 33328591 Free PMC article. Clinical Trial. No abstract available.
196 results